doi:10.36849/JDD.6550 Samantha Ouellette BA, Giulia Frias BA, Radhika Shah MD PharmD, Mahin Alamgir MD, Cindy Wassef MD Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, NJ Abstract Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of antidiabetic agents that work by inducing insulin secretion and inhibiting release of glucagon in a glucose-dependent manner
The negatives depend on the peptide
Neuropharmacology 136(Pt B): 343349
Maximum inhibition generally occurs within 1 h, and is followed by rapid recovery
When it comes to sexual health, peptides offer unique benefits that go beyond traditional treatments
Not recommended during pregnancy or lactation without medical advice